Privacy Bills Should Focus On Compliance Date, Preemption, Lobbyist Says
This article was originally published in The Gray Sheet
Executive Summary
Medical privacy legislation should focus on rolling back the compliance date of the HHS regulations and granting federal preemption of state privacy laws rather than addressing details of the regs, Healthcare Leadership Council Executive VP Alan Mertz said.
You may also be interested in...
Registry Guidance Sought Following HHS Privacy Rule Implementation
Manufacturers seeking protected health information (PHI) from covered entities for postmarket surveillance will need to take precautions to ensure their studies are subject to FDA oversight, and thereby exempted from HHS' privacy rule.
Forthcoming HHS Guidelines Will Clarify Questions On Final Privacy Rule
A yearlong modification period will enable manufacturers, providers and health plans to persuade HHS Secretary Tommy Thompson to change standards or implementation specifications of the final medical privacy rule, which went into effect April 14.
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.